These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25859279)

  • 1. Evaluation of epicardial adipose tissue in familial partial lipodystrophy.
    Godoy-Matos AF; Valério CM; Bragança JB; Oliveira Rde A; Zagury RL; Lustosa Rde P; Camargo GC; Nascimento CA; Moreira RO
    Diabetol Metab Syndr; 2015; 7():29. PubMed ID: 25859279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An imaging study of body composition including lipodeposition pattern in a patient of familial partial lipodystrophy (Dunnigan type).
    Pandey SN; Pungavkar SA; Vaidya RA; Patkar D; Hegele RA; Sheth FJ; Sheth J; Shah SS; Vaidya AB
    J Assoc Physicians India; 2005 Oct; 53():897-900. PubMed ID: 16459536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body composition study by dual-energy x-ray absorptiometry in familial partial lipodystrophy: finding new tools for an objective evaluation.
    Valerio CM; Zajdenverg L; de Oliveira JE; Mory PB; Moyses RS; Godoy-Matos AF
    Diabetol Metab Syndr; 2012 Aug; 4(1):40. PubMed ID: 22938045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for diabetes in familial partial lipodystrophy, Dunnigan variety.
    Haque WA; Oral EA; Dietz K; Bowcock AM; Agarwal AK; Garg A
    Diabetes Care; 2003 May; 26(5):1350-5. PubMed ID: 12716787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective targeting of angiopoietin-like 3 (ANGPTL3) with vupanorsen for the treatment of patients with familial partial lipodystrophy (FPLD): results of a proof-of-concept study.
    Foss-Freitas MC; Akinci B; Neidert A; Bartlett VJ; Hurh E; Karwatowska-Prokopczuk E; Oral EA
    Lipids Health Dis; 2021 Dec; 20(1):174. PubMed ID: 34865644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoplasmic reticulum stress activation in adipose tissue induces metabolic syndrome in individuals with familial partial lipodystrophy of the Dunnigan type.
    Foss-Freitas MC; Ferraz RC; Monteiro LZ; Gomes PM; Iwakura R; de Freitas LCC; Foss MC
    Diabetol Metab Syndr; 2018; 10():6. PubMed ID: 29449893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fitting the pieces of the puzzle together: a case report of the Dunnigan-type of familial partial lipodystrophy in the adolescent girl.
    Krawiec P; Mełges B; Pac-Kożuchowska E; Mroczkowska-Juchkiewicz A; Czerska K
    BMC Pediatr; 2016 Mar; 16():38. PubMed ID: 26976018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and imaging features of women with polygenic partial lipodystrophy: a case series.
    Loh WJ; Yaligar J; Hooper AJ; Sadananthan SA; Kway Y; Lim SC; Watts GF; Velan SS; Leow MKS; Khoo J
    Nutr Diabetes; 2024 Feb; 14(1):3. PubMed ID: 38321009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting abdominal adipose tissue among women with familial partial lipodystrophy.
    Joy T; Kennedy BA; Al-Attar S; Rutt BK; Hegele RA
    Metabolism; 2009 Jun; 58(6):828-34. PubMed ID: 19375764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LMNA R482Q mutation in partial lipodystrophy associated with reduced plasma leptin concentration.
    Hegele RA; Cao H; Huff MW; Anderson CM
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3089-93. PubMed ID: 10999791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term efficacy of leptin replacement in patients with Dunnigan-type familial partial lipodystrophy.
    Park JY; Javor ED; Cochran EK; DePaoli AM; Gorden P
    Metabolism; 2007 Apr; 56(4):508-16. PubMed ID: 17379009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new method for body fat evaluation, body adiposity index, is useful in women with familial partial lipodystrophy.
    Godoy-Matos AF; Moreira RO; Valerio CM; Mory PB; Moises RS
    Obesity (Silver Spring); 2012 Feb; 20(2):440-3. PubMed ID: 22095113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type 1 familial partial lipodystrophy: understanding the Köbberling syndrome.
    Guillín-Amarelle C; Sánchez-Iglesias S; Castro-Pais A; Rodriguez-Cañete L; Ordóñez-Mayán L; Pazos M; González-Méndez B; Rodríguez-García S; Casanueva FF; Fernández-Marmiesse A; Araújo-Vilar D
    Endocrine; 2016 Nov; 54(2):411-421. PubMed ID: 27473102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased skeletal muscle volume in women with familial partial lipodystrophy, Dunnigan variety.
    Ji H; Weatherall P; Adams-Huet B; Garg A
    J Clin Endocrinol Metab; 2013 Aug; 98(8):E1410-3. PubMed ID: 23783098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Metabolic Equivalent BMI in Patients with Familial Partial Lipodystrophy (FPLD) Compared with Those with Severe Obesity.
    Koo E; Foss-Freitas MC; Meral R; Ozer M; Eldin AJ; Akinci B; Miller N; Rothberg AE; Oral EA
    Obesity (Silver Spring); 2021 Feb; 29(2):274-278. PubMed ID: 33491315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epicardial fat: the role of testosterone and lipid metabolism in a cohort of patients with Klinefelter syndrome.
    Granato S; Barbaro G; Di Giorgio MR; Rossi FM; Marzano C; Impronta F; Spaziani M; Anzuini A; Lenzi A; Radicioni AF
    Metabolism; 2019 Jun; 95():21-26. PubMed ID: 30878494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial partial lipodystrophy: a monogenic form of the insulin resistance syndrome.
    Hegele RA
    Mol Genet Metab; 2000 Dec; 71(4):539-44. PubMed ID: 11136544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with familial partial lipodystrophy of the Dunnigan type due to a LMNA R482W mutation show muscular and cardiac abnormalities.
    Vantyghem MC; Pigny P; Maurage CA; Rouaix-Emery N; Stojkovic T; Cuisset JM; Millaire A; Lascols O; Vermersch P; Wemeau JL; Capeau J; Vigouroux C
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5337-46. PubMed ID: 15531479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body fat distribution in women with familial partial lipodystrophy caused by mutation in the lamin A/C gene.
    Monteiro LZ; Foss-Freitas MC; Júnior Montenegro RM; Foss MC
    Indian J Endocrinol Metab; 2012 Jan; 16(1):136-8. PubMed ID: 22276265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of Dunnigan-type familial partial lipodystrophy (FPLD) due to lamin A/C (LMNA) mutations complicated by end-stage renal disease.
    Imachi H; Murao K; Ohtsuka S; Fujiwara M; Muraoka T; Hosokawa H; Ishida T
    Endocrine; 2009 Feb; 35(1):18-21. PubMed ID: 19011997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.